28 June 2010
The government looks into ghostwriting of scientific articles in medical journals: http://bit.ly/d6eM9U. The well-established procedure is: (1) pharmaceutical company does a study, (2) pharmaceutical company maintains the database, (3) pharmaceutical company hires a medical writer to write the article, and (4) pharmaceutical company arranges with a top academic professor to put his or her name as the lead author. Ghostwriting, if it were a Harvard student putting his name on the product, would be considered plagiarism. The student would typically be expelled.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment